1-9717608-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_005026.5(PIK3CD):c.1002C>T(p.Asn334Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,614,064 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0048 ( 12 hom., cov: 32)
Exomes 𝑓: 0.00063 ( 6 hom. )
Consequence
PIK3CD
NM_005026.5 synonymous
NM_005026.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.927
Genes affected
PIK3CD (HGNC:8977): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta) Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 1-9717608-C-T is Benign according to our data. Variant chr1-9717608-C-T is described in ClinVar as [Benign]. Clinvar id is 541092.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-9717608-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.927 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00479 (730/152330) while in subpopulation AFR AF= 0.0164 (682/41586). AF 95% confidence interval is 0.0154. There are 12 homozygotes in gnomad4. There are 341 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIK3CD | NM_005026.5 | c.1002C>T | p.Asn334Asn | synonymous_variant | Exon 8 of 24 | ENST00000377346.9 | NP_005017.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00478 AC: 728AN: 152212Hom.: 12 Cov.: 32
GnomAD3 genomes
AF:
AC:
728
AN:
152212
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00136 AC: 341AN: 250744Hom.: 3 AF XY: 0.000832 AC XY: 113AN XY: 135756
GnomAD3 exomes
AF:
AC:
341
AN:
250744
Hom.:
AF XY:
AC XY:
113
AN XY:
135756
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000629 AC: 919AN: 1461734Hom.: 6 Cov.: 32 AF XY: 0.000575 AC XY: 418AN XY: 727174
GnomAD4 exome
AF:
AC:
919
AN:
1461734
Hom.:
Cov.:
32
AF XY:
AC XY:
418
AN XY:
727174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00479 AC: 730AN: 152330Hom.: 12 Cov.: 32 AF XY: 0.00458 AC XY: 341AN XY: 74488
GnomAD4 genome
AF:
AC:
730
AN:
152330
Hom.:
Cov.:
32
AF XY:
AC XY:
341
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Oct 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
PIK3CD: BP4, BP7, BS1, BS2 -
Oct 08, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Immunodeficiency 14 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at